Rutherford, United States
Glucotrack, founded in 1999, is a pioneering entity in the Health Care and Medical Devices sectors, primarily focusing on technologies for diabetes management. With its headquarters in the United States, the company is committed to creating solutions that amplify the freedom of people living with diabetes, underscoring their slogan, "We create cutting-edge technologies that aim to give people living with diabetes more freedom."
The company is at the forefront of transforming diabetes management through innovative solutions that combine accuracy and ease of use. Their strategic vision emphasizes reducing the daily burden for individuals managing diabetes, thus empowering them in a more effective manner.
Glucotrack recently secured a significant investment of $5.50M in an acquisition on 01 August 2026. This investment marks a pivotal milestone in advancing their mission, despite the lack of disclosed investors. As a venture opportunity, Glucotrack represents a promising investment in cutting-edge medical technologies, particularly in the diabetes management space.
